(Q46465321)

English

The rationale engineering of BCR/ABL blockers: an answer to STI571 acquired resistance in leukemia treatment

scientific article published on 16 February 2005

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

title

The rationale engineering of BCR/ABL blockers: an answer to STI571 acquired resistance in leukemia treatment (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

1 reference

1 reference

Ireneusz J Majsterek

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

publication date

16 February 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

published in

Leukemia Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

volume

29

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

page(s)

605-606

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

Identifiers

DOI

10.1016/J.LEUKRES.2004.11.019

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

PubMed publication ID

15863197

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15863197

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15863197

(Q46465321)

The rationale engineering of BCR/ABL blockers: an answer to STI571 acquired resistance in leukemia treatment

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)